This mechanism involving inhibition of glycolysis by metabolic modulators could be especially effective in tumours overexpressing UCP2, since their uncoupled mitochondria are unable to produce compensatory ATP from respiration [148]. This evidence concerns the gene UCP2 and neoplasm.